Cargando…

Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019

Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoefler, Florence, Pouget-Abadie, Xavier, Roncato-Saberan, Mariam, Lemarié, Romain, Takoudju, Eve-Marie, Raffi, François, Corvec, Stéphane, Le Bras, Morgane, Cazanave, Charles, Lehours, Philippe, Guimard, Thomas, Allix-Béguec, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707594/
https://www.ncbi.nlm.nih.gov/pubmed/36418019
http://dx.doi.org/10.3201/eid2812.220748
_version_ 1784840734522736640
author Hoefler, Florence
Pouget-Abadie, Xavier
Roncato-Saberan, Mariam
Lemarié, Romain
Takoudju, Eve-Marie
Raffi, François
Corvec, Stéphane
Le Bras, Morgane
Cazanave, Charles
Lehours, Philippe
Guimard, Thomas
Allix-Béguec, Caroline
author_facet Hoefler, Florence
Pouget-Abadie, Xavier
Roncato-Saberan, Mariam
Lemarié, Romain
Takoudju, Eve-Marie
Raffi, François
Corvec, Stéphane
Le Bras, Morgane
Cazanave, Charles
Lehours, Philippe
Guimard, Thomas
Allix-Béguec, Caroline
author_sort Hoefler, Florence
collection PubMed
description Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcomes and disease dynamics may help in patient management. We conducted a multicenter case-series study documenting Vibrio infections in 67 patients from 8 hospitals in the Bay of Biscay, France, over a 19-year period. Infections were mainly caused by V. alginolyticus (34%), V. parahaemolyticus (30%), non-O1/O139 V. cholerae (15%), and V. vulnificus (10%). Drug-susceptibility testing revealed intermediate and resistant strains to penicillins and first-generation cephalosporins. The acute infections (e.g., those involving digestive disorder, cellulitis, osteitis, pneumonia, and endocarditis) led to a life-threatening event (septic shock), amputation, or death in 36% of patients. Physicians may need to add vibriosis to their list of infections to assess in patients with associated risk factors.
format Online
Article
Text
id pubmed-9707594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-97075942022-12-09 Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 Hoefler, Florence Pouget-Abadie, Xavier Roncato-Saberan, Mariam Lemarié, Romain Takoudju, Eve-Marie Raffi, François Corvec, Stéphane Le Bras, Morgane Cazanave, Charles Lehours, Philippe Guimard, Thomas Allix-Béguec, Caroline Emerg Infect Dis Synopsis Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcomes and disease dynamics may help in patient management. We conducted a multicenter case-series study documenting Vibrio infections in 67 patients from 8 hospitals in the Bay of Biscay, France, over a 19-year period. Infections were mainly caused by V. alginolyticus (34%), V. parahaemolyticus (30%), non-O1/O139 V. cholerae (15%), and V. vulnificus (10%). Drug-susceptibility testing revealed intermediate and resistant strains to penicillins and first-generation cephalosporins. The acute infections (e.g., those involving digestive disorder, cellulitis, osteitis, pneumonia, and endocarditis) led to a life-threatening event (septic shock), amputation, or death in 36% of patients. Physicians may need to add vibriosis to their list of infections to assess in patients with associated risk factors. Centers for Disease Control and Prevention 2022-12 /pmc/articles/PMC9707594/ /pubmed/36418019 http://dx.doi.org/10.3201/eid2812.220748 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Synopsis
Hoefler, Florence
Pouget-Abadie, Xavier
Roncato-Saberan, Mariam
Lemarié, Romain
Takoudju, Eve-Marie
Raffi, François
Corvec, Stéphane
Le Bras, Morgane
Cazanave, Charles
Lehours, Philippe
Guimard, Thomas
Allix-Béguec, Caroline
Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title_full Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title_fullStr Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title_full_unstemmed Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title_short Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
title_sort clinical and epidemiologic characteristics and therapeutic management of patients with vibrio infections, bay of biscay, france, 2001–2019
topic Synopsis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707594/
https://www.ncbi.nlm.nih.gov/pubmed/36418019
http://dx.doi.org/10.3201/eid2812.220748
work_keys_str_mv AT hoeflerflorence clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT pougetabadiexavier clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT roncatosaberanmariam clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT lemarieromain clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT takoudjuevemarie clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT raffifrancois clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT corvecstephane clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT lebrasmorgane clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT cazanavecharles clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT lehoursphilippe clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT guimardthomas clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019
AT allixbegueccaroline clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019